Rhabdomyosarcoma
New rhabdomyosarcoma models allow investigators to differentiate tumor tissues
Published in Angiogenesis Weekly, October 13th, 2006
"Discosoma sp red fluorescent protein (DsRed2) is a newly developed marker for in vivo labeling studies in different biologic systems. After vector transfection, DsRed2 is expressed in mammalian cells and can be detected by fluorescence microscopy," researchers in Germany reported.
"The aims of this study were to establish a DsRed2-transfected human rhabdomyosarcoma (RMS) cell line and to perform a xenotransplantation on nude mice to use imaging as a tool for further basic research studies on this neoplasm. The human alveolar RMS cell line Rh30 was transfected with the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Angiogenesis Weekly
Source: Angiogenesis Weekly (2006-10-13)
More Articles from Angiogenesis Weekly
- Breast Cancer
Angiogenesis protein increases in breast tissue cultured with estradiol - Breast Cancer
Breast cancer progression is indicated by angiogenesis biomarkers - Drug Development
Tumor angiogenesis is staunched by liposomal-based macrophage depletion - Fitness & Wellness
Diminished cardiac angiogenesis in the aged heart is counteracted by exercise training - Ovarian Cancer
Ovarian tumor growth and angiogenesis increase in chronically stressed murine models - Adipose Tissue
Adipose-derived cells may differentiate into functional smooth muscle cells - More from this issue of Angiogenesis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
